Key result
Preoperative persistent AF linked to ~94% higher long-term mortality after LVAD implantation.
Why the study?
Does the presence and type of preoperative atrial fibrillation (paroxysmal vs. persistent/permanent) increase all-cause mortality in patients undergoing durable left ventricular assist device implantation?
Cohort
No
Does the presence and type of preoperative atrial fibrillation (paroxysmal vs. persistent/permanent) increase all-cause mortality in patients undergoing durable left ventricular assist device implantation?
Preoperative persistent or permanent atrial fibrillation, but not paroxysmal atrial fibrillation, is independently associated with significantly increased 30-day, 2-year, and long-term all-cause mortality following durable LVAD implantation.
Answers are grounded in this paper and cite their sources.
Preoperative persistent/permanent AF was associated with higher post-LVAD mortality; leaves open whether rhythm control improves survival in this population.
A preoperative history of atrial fibrillation (AF) in patients receiving durable left ventricular assist device (LVAD) implantation has been associated with postoperative morbidity and mortality. It is uncertain how the type of preoperative AF (paroxysmal vs. persistent/permanent) impacts clinical outcomes in patients on LVAD support. We sought to determine how the presence and type of preoperative AF affect patient mortality following LVAD implantation. A single-center retrospective analysis was performed of patients who underwent LVAD implantation from 2006-2022. Patients with AF prior to LVAD implantation were characterized as having paroxysmal or persistent/permanent AF for comparison. A total of 289 patients (37%) with a history of preoperative AF underwent LVAD implantation. Paroxysmal AF (78.9%) was more common prior to LVAD implant than persistent/permanent AF (21.1%). The incidence of 30-day and 2-year all-cause mortality were significantly higher amongst patients with preoperative persistent/permanent AF compared to patients without reoperative AF (30-day mortality: 16.4% vs 6.4%, p=0.005; 2-year all-cause mortality: 44.3% vs 24.2%, p=0.001). Over long-term follow-up, the risk of all-cause mortality was significantly higher for patients with preoperative persistent/permanent AF compared to patients without preoperative AF controlling for age, sex, race, class III antiarrhythmic medications, destination therapy and device design (sdHR 1.94; 1.34-2.79 95% CI, p≤0.001). In contrast, there was no significant difference in mortality at 30-days or 2-years between patients with preoperative paroxysmal AF and those without preoperative AF (30-day mortality: 5.7% vs 6.4%, p=0.408; 2-year all-cause mortality: 27.2% vs 24.2%, p=0.010). The risk of long-term mortality was also not significantly different (sdHR 1.19; 0.95-1.5 95% CI, p=0.137). In conclusion, a preoperative history of persistent/permanent AF is associated with increased risk of mortality following LVAD implantation, but there is no significant difference in survival between patients with preoperative paroxysmal AF and those without AF.
No takes yet. Share an insight, caveat, or question.
Oates et al. (2026) conducted a cohort in Durable left ventricular assist device (LVAD) implantation with or without preoperative atrial fibrillation. Preoperative persistent/permanent or paroxysmal atrial fibrillation vs. No preoperative atrial fibrillation was evaluated on Long-term all-cause mortality (persistent/permanent AF vs no preoperative AF) (sdHR 1.94, 95% CI 1.34-2.79, p=≤0.001). Preoperative persistent/permanent AF increased long-term all-cause mortality after LVAD implantation compared with no preoperative AF, unlike paroxysmal AF.
Synapse has enriched 10 related papers. Consider them for comparative context: